177 related articles for article (PubMed ID: 18065778)
1. AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease.
Liévens JC; Iché M; Laval M; Faivre-Sarrailh C; Birman S
Hum Mol Genet; 2008 Mar; 17(6):882-94. PubMed ID: 18065778
[TBL] [Abstract][Full Text] [Related]
2. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila.
Liévens JC; Rival T; Iché M; Chneiweiss H; Birman S
Hum Mol Genet; 2005 Mar; 14(5):713-24. PubMed ID: 15677486
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
4. Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease.
Besson MT; Dupont P; Fridell YW; Liévens JC
Hum Mol Genet; 2010 Sep; 19(17):3372-82. PubMed ID: 20566711
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.
Browne SE
Ann N Y Acad Sci; 2008 Dec; 1147():358-82. PubMed ID: 19076457
[TBL] [Abstract][Full Text] [Related]
6. Impairment of the Glial Phagolysosomal System Drives Prion-Like Propagation in a
Davis GH; Zaya A; Pearce MMP
J Neurosci; 2024 May; 44(20):. PubMed ID: 38589228
[TBL] [Abstract][Full Text] [Related]
7. Methylene Blue Partially Rescues Heart Defects in a Drosophila Model of Huntington's Disease.
Heidari R; Monnier V; Martin E; Tricoire H
J Huntingtons Dis; 2015; 4(2):173-86. PubMed ID: 26397898
[TBL] [Abstract][Full Text] [Related]
8. Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program.
Abou-Sleymane G; Chalmel F; Helmlinger D; Lardenois A; Thibault C; Weber C; Mérienne K; Mandel JL; Poch O; Devys D; Trottier Y
Hum Mol Genet; 2006 Mar; 15(5):691-703. PubMed ID: 16434483
[TBL] [Abstract][Full Text] [Related]
9. Akt is altered in an animal model of Huntington's disease and in patients.
Colin E; Régulier E; Perrin V; Dürr A; Brice A; Aebischer P; Déglon N; Humbert S; Saudou F
Eur J Neurosci; 2005 Mar; 21(6):1478-88. PubMed ID: 15845076
[TBL] [Abstract][Full Text] [Related]
10. Myelinosome Organelles in the Retina of R6/1 Huntington Disease (HD) Mice: Ubiquitous Distribution and Possible Role in Disease Spreading.
Yefimova MG; Béré E; Cantereau-Becq A; Meunier-Balandre AC; Merceron B; Burel A; Merienne K; Ravel C; Becq F; Bourmeyster N
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884576
[TBL] [Abstract][Full Text] [Related]
11. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.
Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R
J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238
[TBL] [Abstract][Full Text] [Related]
12. Huntington's disease: Neural dysfunction linked to inositol polyphosphate multikinase.
Ahmed I; Sbodio JI; Harraz MM; Tyagi R; Grima JC; Albacarys LK; Hubbi ME; Xu R; Kim S; Paul BD; Snyder SH
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9751-6. PubMed ID: 26195796
[TBL] [Abstract][Full Text] [Related]
13. Targeting HSP70 to motoneurons protects locomotor activity from hyperthermia in Drosophila.
Xiao C; Mileva-Seitz V; Seroude L; Robertson RM
Dev Neurobiol; 2007 Mar; 67(4):438-55. PubMed ID: 17443800
[TBL] [Abstract][Full Text] [Related]
14. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
Chiang MC; Chen HM; Lai HL; Chen HW; Chou SY; Chen CM; Tsai FJ; Chern Y
Hum Mol Genet; 2009 Aug; 18(16):2929-42. PubMed ID: 19443488
[TBL] [Abstract][Full Text] [Related]
15. Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease.
Benraiss A; Mariani JN; Osipovitch M; Cornwell A; Windrem MS; Villanueva CB; Chandler-Militello D; Goldman SA
Cell Rep; 2021 Jul; 36(1):109308. PubMed ID: 34233199
[TBL] [Abstract][Full Text] [Related]
16. Nonmammalian Models of Huntington's Disease.
Chongtham A; Barbaro B; Filip T; Syed A; Huang W; Smith MR; Marsh JL
Methods Mol Biol; 2018; 1780():75-96. PubMed ID: 29856015
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of metabolism rescue cell death in Huntington's disease models.
Varma H; Cheng R; Voisine C; Hart AC; Stockwell BR
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14525-30. PubMed ID: 17726098
[TBL] [Abstract][Full Text] [Related]
18. Ciliary neurotrophic factor-mediated signaling regulates neuronal versus glial differentiation of retinal stem cells/progenitors by concentration-dependent recruitment of mitogen-activated protein kinase and Janus kinase-signal transducer and activator of transcription pathways in conjunction with Notch signaling.
Bhattacharya S; Das AV; Mallya KB; Ahmad I
Stem Cells; 2008 Oct; 26(10):2611-24. PubMed ID: 18669911
[TBL] [Abstract][Full Text] [Related]
19. Glial expression of disease-associated poly-glutamine proteins impairs the blood-brain barrier in Drosophila.
Yeh PA; Liu YH; Chu WC; Liu JY; Sun YH
Hum Mol Genet; 2018 Jul; 27(14):2546-2562. PubMed ID: 29726932
[TBL] [Abstract][Full Text] [Related]
20. Dynamic regulation of molecular chaperone gene expression in polyglutamine disease.
Huen NY; Chan HY
Biochem Biophys Res Commun; 2005 Sep; 334(4):1074-84. PubMed ID: 16039613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
